logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9371357 B1

PDFFull Text
Expired
Date of Patent:
Jun. 21, 2016

Filed:

Mar. 04, 2014

Inhibitors of viral integrase and methods of use

Applicants:

Integratech Proteomics, Llc, Salt Lake City, UT (US);

The United States of America, As Represented BY the Secretary, Department of Health and Human Service, Washington, DC (US);

Inventors:

Tanya Sandrock, Salt Lake City, UT (US);

Robert Craigie, Silver Spring, MD (US);

Assignees:

Integratech Proteomics, LLC, Salt Lake City, UT (US);

National Institutes of Health, Bethesda, MD (US);

Attorney:

Meunier Carlin & Curfman LLC

Primary Examiner:

James H Alstrum Acevedo

Assistant Examiner:

Thea D'Ambrosio

Int. Cl.
CPC ...
A01N 37/18 (2006.01); A61K 38/00 (2006.01); A61P 31/18 (2006.01); A61P 31/12 (2006.01); A61K 38/10 (2006.01); A61K 38/16 (2006.01); A61K 38/04 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01); C07K 1/00 (2006.01); C07K 4/00 (2006.01); C07K 7/08 (2006.01); G01N 33/573 (2006.01); A61K 38/03 (2006.01); A61K 39/00 (2006.01); C07K 7/02 (2006.01); C12Q 1/68 (2006.01); C12Q 1/70 (2006.01); C40B 30/04 (2006.01);
U.S. Cl.
CPC ...
C07K 4/00 (2013.01); A61K 38/00 (2013.01); A61K 38/03 (2013.01); A61K 38/10 (2013.01); A61K 39/00 (2013.01); C07K 7/02 (2013.01); C07K 7/08 (2013.01); C12Q 1/68 (2013.01); C12Q 1/70 (2013.01); C40B 30/04 (2013.01); G01N 33/573 (2013.01); C07K 1/00 (2013.01); G01N 2333/15 (2013.01); G01N 2500/02 (2013.01);
Abstract

Described herein are compositions and methods for inhibiting HIV integrase activity. Also described are methods of identifying agents that inhibit HIV integrase for use in treating or preventing HIV. Also disclosed are methods of identifying agents that inhibit HIV viral mutants that are resistant to integrase inhibitors.

Find Patent Forward Citations

Sandrock, Tanya. (2016). Inhibitors of viral integrase and methods of use (U.S. Patent No. 9371357). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9371357

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…